For instance, daytime fatigue may be improved in several ways
4 Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, Lille, France
These pharmaceutical drugs have since gained approval for the treatment of obesity
Retatrutide is an innovative new drug that focuses on several hormone pathways to curb appetite and promote weight loss
Many patients describe a noticeable increase in energy and motivation when starting bupropion, a welcome change from the lethargy that depression causes and from the fatigue some people experience on tirzepatide
Key highlights: Once-daily oral administration No food or water restrictions No injections required ~12% mean weight loss in Phase 3 trials Improvements in cardiometabolic risk markers Indication: Approved for adults with obesity, or overweight individuals with weight-related comorbidities, alongside reduced-calorie diet and increased physical activity